- Thursday, June 10, 2010, 12:39
- Liver Disease
- 922
Liver diseases are damaged the function of hapetocytes, it may causes hepatocellular necrosis, fibrosis, and regeneration with nodule formation.
Chronic liver disease in which liver damage slowly by process and persisting over long time.It means it act as slow poison for healthy human body. It is characterized by replacement of liver tissue by fibrous scar tissue as well as regenerative nodules (lumps that occurs as a ...
Full story
- Wednesday, March 10, 2010, 1:46
- Liver Disease
- 370
Several processes can lead to cirrhosis.
Alcoholism
Alcoholism particularly endangers the liver. Alcoholic cirrhosis (also sometimes referred to as portal, Laennec's, nutritional, or micronodular cirrhosis) is the primary cause of cirrhosis in the U.S. It is estimated to be responsible for 44% of deaths from cirrhosis in North America. Some experts believe this estimate is low. One Canadian study found alcohol to be the major contributor to ...
Full story
- Wednesday, December 2, 2009, 5:44
- Health News
- 14
Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that its partner Tripep AB of Sweden has completed its phase I clinical study of its ChronVac-C hepatitis C virus DNA vaccine delivered using Inovio's electroporation technology. The study established the safety and tolerability of this therapy, with vaccine-induced immune responses and transient effects on the serum levels of ...
Full story
- Tuesday, December 1, 2009, 15:50
- Health News
- 5
New peer-reviewed data finding that fewer than one-fifth of the nearly 4 million Americans infected with chronic hepatitis C virus have received anti-viral therapy in recent years should be a wake-up call that Congress needs to move urgently on bipartisan legislation to support new state-based detection, research, and surveillance efforts, the National Viral Hepatitis Roundtable (NVHR) said today...
...
Full story
- Monday, November 30, 2009, 14:40
- Health News
- 6
All samples from the 12 patients with chronic Hepatitis C genotype 1 treated with Tripep's therapeutic vaccine ChronVac-C® have now been collected. The treatment was found to be safe, immunogenic and had transient effects on the serum levels of hepatitis C virus. This provides a proof-of-concept for the therapeutic strategy.
Go to Source Full story
- Monday, November 9, 2009, 17:03
- Liver Disease
- 456
Hepatitis C is a disease of the liver that is caused by the hepatitis C virus, or HCV.
Between 15 to 40 percent of people who get hepatitis C are able to fight off the virus during the early, or acute, stage, usually within six months. Between 60 and 85 percent of patients cannot get rid of the virus and develop a long-term, or chronic, hepatitis ...
Full story